UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 12b-25
 
 
SEC File Number 333-192272
 
CUSIP Number 04521X109
 
NOTIFICATION OF LATE FILING
 
(Check One):
[  ] Form 10-K       [  ] Form 11-K            [  ] Form 20-F        [X] Form 10-Q
 
[  ] Form 10-D       [  ] Form N-SAR        [  ] Form N-CSR
 
 
For Period Ended: September 30, 2017
 
 
 
[  ] Transition Report on Form 10-K
 
 
 
[  ] Transition Report on Form 20-F
 
 
 
[  ] Transition Report on Form 11-K
 
 
 
[  ] Transition Report on Form 10-Q
 
 
 
[  ] Transition Report on Form N-SAR
 
 
 
For Transition Period Ended:_________________________________________________
 
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
 
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
 
PART I – REGISTRANT INFORMATION
 
Kraig Biocraft Laboratories, Inc.
Full Name of Registrant
 
2723 South State St, Suite 150
Address of Principal Executive Office  (Street and Number)
 
Ann Arbor, Michigan 48194
City, State and Zip Code
 
 
 
 
PART II – RULE 12-b 25 (b) AND (c)
 
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)
 
 
(a)
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
 
 
 
[X]
(b)
The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
 
 
 
 
(c)
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
PART III – NARRATIVE
 
State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report portion thereof could not be filed within the prescribed time period. (Attach extra sheets if needed.)
 
The Registrant is unable to file its Form 10-Q within the prescribed time period without unreasonable effort or expense due to the fact that it has not completed the process of preparing and integrating operating information into statements for the fiscal quarter ended September 30, 2017. The Registrant anticipates that it will file its Form 10-Q within the five-day grace period provided by Exchange Act Rule 12b-25.
 
PART IV – OTHER INFORMATION
 
(1)
Name and telephone number of person to contact in regard to this notification
 
Kim Thompson
 
734
 
619-8066
(Name)
 
(Area Code)
 
(Telephone Number)
 
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
 
 
 
[X] Yes [  ] No
 
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
 
 
 
[  ] Yes [X] No
 
If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
 
 
 
Kraig Biocraft Laboratories, Inc.
(Name of Registrant as Specified in Charter)
 
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
 
Date: November 15, 2017
By:
  / s / Kim Thompson
 
 
Kim Thompson
 
 
President, Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial and Accounting Officer)
 
 
 
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Kraig Biocraft Laborator... (QB).
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Kraig Biocraft Laborator... (QB).